Cathinone
Cathinone is a stimulant compound — the natural active ingredient in the khat plant, and the chemical parent of the synthetic 'bath salts' family (mephedrone, MDPV, methylone, alpha-PVP/'flakka' and others). Structurally related to amphetamine, cathinones range from the mild natural compound to potent, dangerous synthetics linked to psychosis and death. Natural cathinone is Schedule I in the US; most synthetic cathinones are Schedule I or prosecutable as analogues.
Overview
Cathinone is a naturally occurring stimulant found in the leaves of the khat plant (Catha edulis), and it is the structural template for a large family of synthetic derivatives known as substituted or synthetic cathinones — the drugs widely sold as 'bath salts'. The natural compound produces a mild, khat-chewing stimulation; the synthetic derivatives, engineered to mimic and often exceed cocaine, methamphetamine, and MDMA, are far more potent and dangerous. This page covers the cathinone class as a whole; for the natural plant see the khat page, and for specific synthetic members see the mephedrone, MDPV, methylone, and 3-MMC pages.
Source: DEA; NIDA; peer-reviewed literature (NIH/PMC)
Chemistry & mechanism of action
Cathinones are structurally related to amphetamine and act as central nervous system stimulants: they increase the activity of dopamine, norepinephrine, and serotonin by promoting their release and blocking their reuptake, raising levels of these neurotransmitters in the brain. This produces stimulation, euphoria, and alertness. Synthetic cathinones vary widely in potency and which transporters they target — some (like MDPV) are extremely potent dopamine-norepinephrine reuptake inhibitors, which contributes to their intense, compulsive, and dangerous effects compared with the mild natural compound.
Source: NIDA; peer-reviewed literature (NIH/PMC)
Effects
Effects are stimulant-like: euphoria, increased energy, alertness, sociability, and raised heart rate and blood pressure. The natural cathinone in khat is comparatively mild; synthetic cathinones can produce powerful stimulation resembling cocaine, methamphetamine, or MDMA, often with a strong compulsion to redose. Higher doses and more potent synthetics bring agitation, paranoia, hallucinations, and — notably — a documented pattern of severe, sometimes violent, psychotic episodes ('excited delirium'). A comedown with fatigue, low mood, and craving is common.
Source: NIDA; peer-reviewed literature (NIH/PMC)
Risks & harms
The natural cathinone in khat is a relatively mild stimulant, but synthetic cathinones ('bath salts') are among the more dangerous stimulants in circulation. They strain the cardiovascular system — dangerously high heart rate, blood pressure, chest pain, and risk of heart attack and stroke — and can cause severe hyperthermia (overheating), seizures, kidney failure, and rhabdomyolysis (muscle breakdown). Psychiatrically they are notorious for agitation, paranoia, hallucinations, and violent, self-endangering 'excited delirium', which has been linked to deaths. Because formulas change constantly to evade the law, potency and identity are wildly unpredictable, dosing is guesswork, and products sold as one cathinone are frequently another or a mixture; contamination, including with fentanyl in the broader illicit supply, is a risk. Dependence and compulsive redosing develop readily. Injecting or sharing equipment adds infection risk. Anyone showing dangerously high temperature, chest pain, seizures, extreme agitation or psychosis, or collapse needs emergency care — call 911, and Poison Control at 1-800-222-1222 can advise. This page has not yet been medically reviewed.
Source: NIDA; DEA; SAMHSA; peer-reviewed literature (NIH/PMC)
Legal status (US)
In the United States, cathinone itself (the natural khat compound) is a Schedule I controlled substance, as is methcathinone; cathine, the milder compound khat degrades into, is Schedule IV. Among synthetic cathinones, mephedrone and MDPV were permanently placed in Schedule I by the Synthetic Drug Abuse Prevention Act of 2012 (effective July 9, 2012), and methylone was permanently scheduled by the DEA in 2013; the DEA has since placed at least ten additional synthetic cathinones (including alpha-PVP/'flakka') into Schedule I. Crucially, newer cathinones not yet named on a schedule can still be prosecuted as Schedule I substances under the Federal Analogue Act when intended for human consumption — the reason clandestine chemists' constant reformulating does not make these drugs legal. Follow local law; consult DEA and Federal Register resources for specifics. This page has not yet been medically reviewed.
Source: DEA; US federal law (Synthetic Drug Abuse Prevention Act 2012; Federal Analogue Act, 21 U.S.C. 813); Federal Register
Drug laws and enforcement change and vary by country. This is not legal advice. Always confirm with the destination’s embassy or official drug authority before traveling — penalties can be severe, including imprisonment.
Before you travel
Verify current rules with the destination country’s official drug authorityand your own country’s embassy before traveling. Find the destination’s U.S. embassy & official country guidance →
Non-U.S. travelers: check your own government’s travel advisory and embassy.
If you’re detained or arrested abroad
Contact your own country’s embassy or consulatein the destination immediately — notthe destination’s authorities. U.S. citizens: contact the nearest U.S. embassy/consulate and the U.S. State Department at +1-202-501-4444 (from abroad). If a U.S. citizen is arrested or detained abroad →
Images
Visual references coming soon.
If it’s too intense
If an experience becomes overwhelming, the goal is to stay safe and let it pass — most difficult experiences ease as the drug wears off.
- Get to a calm, safe space with someone you trust who is sober and can stay with you.
- Cool down if you’re overheating — move somewhere cool, remove extra layers, rest. Overheating is especially a risk with stimulants and MDMA.
- Sip water to thirst — but don’t over-hydrate. Drinking large amounts of plain water (especially after MDMA) can dangerously dilute your blood sodium (hyponatremia). Electrolytes help more than volume.
- Slow your breathing — long, slow exhales help settle a racing heart and anxiety.
- A sugary drink, fruit juice, or a snack can ease shakiness and the anxiety that comes with low blood sugar.
- Do not take more, and do not add another substance to manage it. Redosing or adding something else (including a sedative like a benzodiazepine) can make things worse, not better.
With stimulants, overheating and a racing heart are the main concerns — get somewhere cool, stop any physical activity, and don't take more.
Source: general harm-reduction guidance from SAMHSA, NIH/NIDA, and MedlinePlus, in our own words. Draft — not yet medically reviewed.
Forensic dossier
Draft · every field is source-cited or marked “Unknown — pending review”Identity
- PubChem CID
- 62258PubChem PUG-REST ↗ · retrieved 2026-06-18
- IUPAC name
- (2S)-2-amino-1-phenylpropan-1-onePubChem PUG-REST ↗ · retrieved 2026-06-18
- Molecular formula
- C9H11NOPubChem PUG-REST ↗ · retrieved 2026-06-18
- SMILES
- C[C@@H](C(=O)C1=CC=CC=C1)NPubChem PUG-REST ↗ · retrieved 2026-06-18
- InChIKey
- PUAQLLVFLMYYJJ-ZETCQYMHSA-NPubChem PUG-REST ↗ · retrieved 2026-06-18
- Synonyms / aliases
- khat, qat, Cathinone, Norephedrone, d-Cathinone, Catinona, Cathinonum, alpha-Aminopropiophenone, S-(-)-cathinone, (-)-alpha-Aminopropiophenone, Cathinine, 1-propanone, 2-amino-1-phenylPubChem PUG-REST + seed aliases ↗ · retrieved 2026-06-18
Composition
- Composition
- N/A — single compound (see Identity)
Physical / pill characteristics
- Dosage form
- Unknown — pending review (no Rx/OTC label; illicit — pill visuals = FIRST-PARTY submissions only, never generated or scraped)
- Route
- Unknown — pending review
- Shape
- Unknown — pending review
- Color
- Unknown — pending review
- Imprint
- Unknown — pending review
- Score
- Unknown — pending review
Scheduling & legal status
- US schedule
- Unknown — pending review
- International
- See EMCDDA/EUDA + WHO — synthesize per jurisdictionEMCDDA / EUDA ↗ · retrieved 2026-06-18
Effects
- Effects
- Cited source pending synthesis — author in our words from NIDA/MedlinePlus on review (NOT auto-generated)NIDA + MedlinePlus ↗ · retrieved 2026-06-18
Risks
- Risks
- Cited source pending synthesis — author in our words from NIDA/MedlinePlus on review (NOT auto-generated)NIDA + MedlinePlus ↗ · retrieved 2026-06-18
Interactions
- Interactions
- Unknown — pending review
Dosage
Pending medical reviewer
